secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2023-09-14T23:59:59+00:00
Accession:  0001493152-23-032553
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ZyVersa Therapeutics induces warrant exercise for up to 12.1M shares; issues new warrants
--------------------------------------------------------------------------------

- Holder to exercise up to 12,121,213 existing warrants at reduced price (lower of that day's close or 5-day average) by Sep 18, 2023.
- In exchange, ZyVersa issues new warrants to purchase same number of shares, exercisable at same reduced price starting 6 months after issuance for 5 years.
- New warrants are unregistered, issued under Section 4(a)(2); existing warrant shares are registered.
- A.G.P./Alliance Global Partners acts as financial advisor with 6% fee on gross proceeds.
- Beneficial ownership blocker set at 4.99% or 9.99% per holder election.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000149315223032553/0001493152-23-032553-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000149315223032553/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-032553

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer